(Q40110805)

17 September 2017

title

Homoharringtonine induces apoptosis and growth arrest in human myeloma cells (English)

1 reference

17 September 2017

0 references

Yin-Jun Lou

1

1 reference

17 September 2017

Wen-Bin Qian

series ordinal

2

1 reference

17 September 2017

Jie Jin

series ordinal

3

1 reference

17 September 2017

publication date

1 July 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

48

1 reference

17 September 2017

issue

7

1 reference

17 September 2017

page(s)

1400-1406

1 reference

Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

Bortezomib treatment for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

Homoharringtonine: a new treatment option for myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

Homoharringtonine: history, current research, and future direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

Homoharringtonine mediates myeloid cell apoptosis via upregulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701411466

10.1080/10428190701411466

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference